Stock CANF CAN-FITE BIOPHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Can-Fite BioPharma Ltd. Nyse

Equities

CANF

US13471N1028

End-of-day quote Nyse
Other stock markets
 06:00:00 2024-02-04 pm EST 		5-day change 1st Jan Change
2.02 USD -3.35% Intraday chart for Can-Fite BioPharma Ltd. -4.04% -8.18%
Apr. 03 Can-Fite Biopharma Ltd. Announces Submission of an Investigational New Drug Application to the U.S. Food and Drug Administration for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis, Also Known as Non-Alcoholic Steatohepatitis, for the Company's Ongoing Phase IIb Clinical Study CI
Mar. 28 Can-Fite Biopharma Ltd. Announces Clinical Update CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CANF Stock
  4. CANF Stock
  5. News Can-Fite BioPharma Ltd.
  6. MarketScreener Strategies